Josh Gottheimer bought Crinetics Pharmaceuticals Inc (NASDAQ: CRNX)
Josh Gottheimer (D-NJ), a U.S. Representative, has disclosed 2 trades in Crinetics Pharmaceuticals Inc (CRNX) since 2024, 1 purchase and 1 sale, worth an estimated $16K in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts).
The trade highlighted here is a purchase: Josh Gottheimer bought $1,001 - $15,000 of Crinetics Pharmaceuticals Inc (NASDAQ: CRNX) on September 25, 2024. Since that trade, CRNX is up +66.26% against the S&P 500 up +30.26%, an outperformance of +36.00%.
Across these filings, Josh Gottheimer has been a balanced trader of CRNX (a buy-to-sell ratio of 1.00). The most recent disclosed CRNX transaction shown was dated March 19, 2025. Each row in the table below links to that trade and its post-trade performance versus the market.
Data updated
Josh Gottheimer's CRNX trades vs the price
CRNX is up +66.26% since Josh Gottheimer bought on September 25, 2024, versus +30.26% for the S&P 500.
Performance since this trade
All Josh Gottheimer CRNX trades
Josh Gottheimer & CRNX trading FAQ
Is it legal for Josh Gottheimer to trade Crinetics Pharmaceuticals Inc (CRNX) stock?
Yes. Members of Congress are allowed to trade individual stocks, including Crinetics Pharmaceuticals Inc (CRNX), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. Quantellect tracks those disclosures; this page does not imply the trade was improper.
When did Josh Gottheimer buy CRNX?
Josh Gottheimer disclosed a purchase of $1,001 - $15,000 of Crinetics Pharmaceuticals Inc (CRNX) on September 25, 2024, according to public STOCK Act filings.
How has CRNX performed since Josh Gottheimer's trade?
Since Josh Gottheimer bought CRNX on September 25, 2024, the stock is up +66.26%, versus +30.26% for the S&P 500 over the same period, an outperformance of +36.00%.
How many times has Josh Gottheimer traded CRNX?
Josh Gottheimer has disclosed 2 CRNX trades since 2024 (1 purchase and 1 sale). Every disclosed trade is listed on this page.
How soon must members of Congress disclose a trade?
Under the STOCK Act, members of Congress must publicly report a covered transaction within 45 days of the trade. Filings can still be delayed, amended, or contain errors.
Where can I see all congressional CRNX trades?
Quantellect tracks every disclosed congressional trade in Crinetics Pharmaceuticals Inc (CRNX) on the Crinetics Pharmaceuticals Inc congressional trading page, which aggregates filings across all members of Congress.
Josh Gottheimer's CRNX tradesAll congressional filings for Crinetics Pharmaceuticals IncJosh Gottheimer's full profile
Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. Estimated prices and post-trade returns are derived algorithmically from public filings and end-of-day market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.